Shopping Cart
- Remove All
Your shopping cart is currently empty
CaCCinh-A01
🥰Excellent
Catalog No. T4330Cas No. 407587-33-1
CaCCinh-A01 is an inhibitor of the calcium-activated chloride channel (CaCC, 10 μM) and TMEM16A (IC50: 2.1 μM).
CaCCinh-A01
🥰Excellent
Purity: 99.92%
Catalog No. T4330Cas No. 407587-33-1
CaCCinh-A01 is an inhibitor of the calcium-activated chloride channel (CaCC, 10 μM) and TMEM16A (IC50: 2.1 μM).
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $52 | In Stock | |
| 10 mg | $84 | In Stock | |
| 25 mg | $189 | In Stock | |
| 50 mg | $313 | In Stock | |
| 100 mg | $528 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $57 | In Stock |
Bulk & Custom
Add to Cart
Questions
View MoreInhibitors Related to "CaCCinh-A01"
Halothane
Narcotane, Anestan
T0954151-67-7
Halothane (Anestan) is a nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required.
- $45
Size
QTY
Fenamic acid
N-Phenylanthranilic acid, Diphenylamine-2-carboxylic acid, 2-Anilinobenzoic acid, 2-(Phenylamino)benzoic acid
T2233091-40-7
Fenamic acid (N-Phenylanthranilic acid) is a chloride channel blocker that causes renal papillary necrosis in rats. Fenamic acid serves as a parent structure for several nonsteroidal anti-inflammatory drugs (NSAIDs), including flufenamic acid, tolfenamic acid, mefenamic acid, and meclofenamic acid.
- $33
Size
QTY
Betaine chloride
Betaine hydrochloride
T0019590-46-5
Betaine chloride (Betaine hydrochloride) is an acidic form of betaine, a vitamin-like substance observed in grains and other foods; gains the amplification of DNA by decreasing the formation of secondary structure in GC-rich regions.
- $29
Size
QTY
Urethane
Cited
Ethylurethane, Ethyl carbamate, Carbamic acid ethyl ester
T005151-79-6
Urethane (Ethylurethane) was an antineoplastic agent .Now is used for other medicinal purposes.
- $29
Size
QTY
CitedSelamectin
Cited
UK-124114
T4059220119-17-5
Selamectin (UK-124114) is a macrocyclic lactone derivative of ivermectin, an anthelmintic that potentiates glutamate- and GABA-gated chloride channel opening in nematodes. In an H. contortus larval development assay, selamectin (0.1 μg/ml) shows the effect of growth inhibition.
- $31
Size
QTY
CitedNiflumic acid Cited
Nifluril, Landruma, Forenol
T06934394-00-7
Niflumic acid (Nifluril) is a Ca2+-activated Cl- channel blocker and an analgesic and anti-inflammatory agent used in the therapy of rheumatoid arthritis.
- $44
Size
QTY
CitedD-Alanine
D-α-Alanine, Ba 2776, (R)-Alanine, (R)-2-Aminopropionic acid
T4811338-69-2
Alanine is a nonessential amino acid made in the body from the conversion of the carbohydrate pyruvate or the breakdown of DNA and the dipeptides carnosine and anserine. D-Alanine ((R)-Alanine) is a weak GlyR (inhibitory glycine receptor) and PMBA agonist, with an EC50 of 9 mM for GlyR.
- $41
Size
QTY
Meticrane
Fontiliz, Arresten
T02751084-65-7
Meticrane (Arresten) is a sulphonamide-derivative with thiazide-like diuretic activity.
- $33
Size
QTY
Lubiprostone
SPI-0211, RU-0211
T6307136790-76-6
Lubiprostone (RU-0211), an activator of ClC-2 chloride channels, is used in the therapy of idiopathic chronic constipation.
- $47
Size
QTY
Adjudin
AF-2364
T2498252025-52-8
Adjudin (AF-2364) is a small molecule compound known to possess antispermatogenic function, attenuates microglia activation by suppression of the NF-κB pathway.
- $48
Size
QTY
Flufenamic acid
Nichisedan, Arlef, Achless
T0858530-78-9
Flufenamic acid (Arlef) is an anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically.
- $33
Size
QTY
Guanidinoethyl sulfonate
Taurocyamine
T21615543-18-0
Guanidinoethyl sulfonate (Taurocyamine) is a competitive glycine receptor antagonist.
- $41
Size
QTY
Select Batch
Purity:99.92%
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.Product Introduction
Bioactivity
Chemical Properties
| Description | CaCCinh-A01 is an inhibitor of the calcium-activated chloride channel (CaCC, 10 μM) and TMEM16A (IC50: 2.1 μM). |
| Targets&IC50 | TMEM16A:2.1 μM, CaCC:10 μM |
| In vitro | Tannic acid (100 μM) and CaCCinh-A01 (30 μM) effectively inhibit CaCC current following ATP stimulation[1]. CaCCinh-A01 (0.1/1/10 μM) reduces Calcium-dependent chloride current (38±14, 66±10, and 91±1%). ATP-induced short-circuits currents are reduced by 38±7 and 78±3% at 10 and 30 μM CaCCinh-A01, respectively. |
| Cell Research | Each well of a 96-well plate is washed three times with PBS (200 μL/wash), leaving 50 μL of PBS. Test compounds (including CaCCinh-A01) (0.5 μL) are added to each well at 25 μM final concentration. After 10 min, 96-well plates are transferred to a plate reader for fluorescence assay. Each well is assayed individually for TMEM16A-mediated I- influx by recording fluorescence continuously (400 ms/point) for 2 s (baseline), then 50 μL of a 140 mM I-solution containing 200 μM ATP is added. |
| Molecular Weight | 347.43 |
| Formula | C18H21NO4S |
| Cas No. | 407587-33-1 |
| Smiles | CC(C)(C)C1CCc2c(C1)sc(NC(=O)c1ccco1)c2C(O)=O |
| Relative Density. | 1.305 g/cm3 (Predicted) |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 55 mg/mL (158.31 mM)  | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Keywords
Preview
Related Tags: buy CaCCinh-A01 | purchase CaCCinh-A01 | CaCCinh-A01 cost | order CaCCinh-A01 | CaCCinh-A01 chemical structure | CaCCinh-A01 in vitro | CaCCinh-A01 formula | CaCCinh-A01 molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.